Open Accelerator: the international program for start-ups in Life Science is back with a new Call for Solutions 26 May 2020
DA IBSA OLTRE 700.000 CHF PER COMBATTERE L’EMERGENZA COVID-19 DI QUESTI 245.000 CHF DONATI DAI LAVORATORI IBSA A SOSTEGNO DELLE FAMIGLIE IN DIFFICOLTÀ 13 May 2020
Helsinn and MEI Pharma Announce Updated Clinical Data from the Phase 2 Study Evaluating Pracinostat in Combination with Azacitidine in Patients with High/Very-high Risk Myelodysplastic Syndromes 13 May 2020
IBSA DONA ALL’UFFICIO DEL MEDICO CANTONALE I TEST SIEROLOGICI PER L’INDIVIDUAZIONE DEGLI ANTICORPI AL COVID-19 8 May 2020
Farma Industria Ticino realizza una filiera produttiva locale di etanolo donando 940 litri all’EOC 23 April 2020
Helsinn Therapeutics (U.S.), Inc. waives copay fees for cancer-treating drug VALCHLOR® (mechlorethamine) gel to ensure eligible patients have access to treatment during the COVID-19 crisis 20 April 2020
IBSA FOUNDATION FELLOWSHIPS: ASSEGNATE 5 NUOVE BORSE DI STUDIO, PERCHÉ LA RICERCA SCIENTIFICA NON DEVE FERMARSI 15 April 2020
IBSA JOINS THE FIGHT AGAINST COVID-19: DONATION OF CHF 500,000 AND MEDICAL SUPPLIES TO HELP THE MOST AFFECTED AREAS 6 April 2020
PRESS RELEASE – Coronavirus: the commitment and dedication of Farma Industria Ticino associated companies 30 March 2020
Linkedin